Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 1 December 2020NewsHumanCOVID-19Vaccines Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up 27 November 2020NewsHumanCOVID-19Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020 27 November 2020NewsHumanCOVID-19PharmacovigilanceReferrals Call for expressions of interest for Committee for Orphan Medicinal Products (COMP) members positions representing patient organisations 24 November 2020NewsHumanCorporateRare diseases Workshop on regulatory support for development of orphan medicines 23 November 2020NewsHumanEarly accessRare diseasesScientific advice Update on remdesivir - EMA will evaluate new data from Solidarity trial 20 November 2020NewsHumanCOVID-19Medicines HMA/EMA statement on approval of vaccines 20 November 2020NewsHumanCOVID-19MedicinesVaccines Call for independent scientific experts to join EMA's Pharmacovigilance Risk Assessment Committee (PRAC) - deadline extended 20 November 2020NewsHumanCorporatePharmacovigilance EMA organises public meeting on COVID-19 vaccines 19 November 2020NewsHumanCOVID-19MedicinesVaccines EMA marks European Antibiotic Awareness Day 18 November 2020NewsHumanAntimicrobial resistance 1 … 72 73 74 75 76 Page 76 of 380 77 78 79 80 … 380
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 1 December 2020NewsHumanCOVID-19Vaccines
Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up 27 November 2020NewsHumanCOVID-19Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020 27 November 2020NewsHumanCOVID-19PharmacovigilanceReferrals
Call for expressions of interest for Committee for Orphan Medicinal Products (COMP) members positions representing patient organisations 24 November 2020NewsHumanCorporateRare diseases
Workshop on regulatory support for development of orphan medicines 23 November 2020NewsHumanEarly accessRare diseasesScientific advice
Update on remdesivir - EMA will evaluate new data from Solidarity trial 20 November 2020NewsHumanCOVID-19Medicines
Call for independent scientific experts to join EMA's Pharmacovigilance Risk Assessment Committee (PRAC) - deadline extended 20 November 2020NewsHumanCorporatePharmacovigilance